Search - tctmd.com

Displaying 1 - 20 of 37

Sort: Relevancy | Date

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Daily News

Regulating Calcium Could Help Regenerate the Heart

Yael L. Maxwell

March 14, 2025

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Conference News EACTS 2022

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Shelley Wood

October 12, 2022

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Industry News

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

April 25, 2018

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

Presentation ESC 2016

Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure

Presenter: Javed Butler

August 28, 2016

News Conference News ESC 2016

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

Shelley Wood

August 28, 2016

News Industry News

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

April 19, 2016

Advertisement

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

Regulating Calcium Could Help Regenerate the Heart

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

November 2022 News Roundup

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Non-ischemic Heart Failure

Another Meeting, Another Mesenchymal Stem Cell Study (or Two), With Mixed Results

CardioCell Completes Enrollment for a Phase IIa Clinical Trial Using Its Stem Cells for Participants With Chronic Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content